Imiquad Sachet (Imiquimod cream) | Used for Genital Warts and Skin Lesion Treatment
Imiquad Sachet 5%, featuring Imiquimod cream, is a medication intended to address various skin conditions. These encompass actinic keratosis, characterized by rough, flat, scaly patches resulting from excessive sun exposure on the face or scalp, as well as skin cell cancer on the trunk, neck, or extremities. Imiquad Sachet 5% is also effective in treating warts on the genital and anal areas, specifically condyloma acuminata. Explore the convenience of purchasing Imiquad Sachet 5% with Imiquimod cream online to address your skin health needs.
Product Overview
Imiquad Sachet, containing Imiquimod, is a prescription immune response modifier used for the topical treatment of specific skin conditions, including actinic keratosis, superficial basal cell carcinoma, and external genital warts.
Imiquad is not a direct antiviral or cytotoxic drug. Instead, it functions as an immune response modifier; when applied to the skin, it stimulates the body’s own immune system to produce interferon-alpha and other cytokines, which help the immune system recognize and destroy abnormal skin cells or viral-infected tissues.
Product Composition
- Active Ingredient: Imiquimod (available in various concentrations, commonly 5%).
- Drug Class: Immune Response Modifier / Topical Immunomodulator.
- Formulation: Topical cream in single-use sachets.
- Key Characteristic: Induces a localized immune-mediated inflammatory response to eliminate target lesions.
Product Specification
| Feature | Details |
| Therapeutic Class | Dermatological / Antineoplastic |
| Primary Indication | Actinic Keratosis, Superficial Basal Cell Carcinoma, External Genital Warts |
| Mechanism | Stimulates innate and acquired immune pathways |
| Administration | Topical application to affected skin areas |
| Storage | Store at room temperature (below 25°C); protect from freezing |
Mechanism of Action
- Cytokine Induction: Imiquimod acts as a toll-like receptor-7 (TLR-7) agonist. Binding to TLR-7 on immune cells induces the release of high levels of interferon-alpha (IFN-$\alpha$), tumor necrosis factor-alpha (TNF-$\alpha$), and various interleukins.
- Immune Activation: This surge of cytokines activates local dendritic cells, macrophages, and T-lymphocytes, which then target and clear the precancerous or cancerous skin cells or viral lesions.
- Localized Response: The drug's effect is highly localized to the site of application, leveraging the body’s natural defense mechanisms rather than systemic chemotherapy.
Key Benefits
- Non-Invasive Treatment: Offers an effective alternative to surgical procedures, cryotherapy, or curettage for certain non-melanoma skin cancers and precancerous lesions.
- Targeted Immune Therapy: Harnesses the patient's immune system, which can help reduce the rate of recurrence for certain conditions.
- Convenience: Single-use sachets ensure accurate dosing and hygiene, suitable for home-based application under medical supervision.
- Cosmetic Outcome: Because it is non-surgical, it often results in superior cosmetic outcomes compared to invasive procedures, especially on delicate skin areas like the face.
Precautions
Important precautions for Imiquad Sachet (Imiquimod Cream)
Application precautions
- For external use only, do not apply inside mouth, eyes, or vagina unless prescribed
- Apply only to the affected area as directed
- Do not cover treated area with tight or occlusive dressings unless advised
- Wash hands before and after application
Skin reaction precautions
- May cause redness, irritation, burning, or peeling at application site
- Mild to moderate skin reactions are common and part of treatment response
- Avoid use on broken, severely inflamed, or infected skin unless directed
- Inform doctor if severe irritation or ulceration occurs
Sun exposure precautions
- Treated skin may become more sensitive to sunlight
- Avoid excessive sun exposure and use protective clothing
- Sunscreen use is recommended during treatment
- Do not use tanning beds or sunlamps
Immune system precautions
- Works by stimulating immune response, effects may vary between individuals
- Use cautiously in patients with autoimmune conditions
- Inform doctor if you have a weakened immune system
- Regular follow-up may be required for monitoring response
General usage precautions
- Use only for prescribed duration and frequency
- Do not use more than recommended amount
- Avoid sexual contact on treated areas while cream is applied
- Inform doctor about all ongoing medications and skin treatments
Safety overview table
| Area of caution | Precaution guidance |
|---|---|
| Application | External use only, apply as directed |
| Skin reaction | May cause irritation, monitor severity |
| Sun exposure | Increased sensitivity, avoid sunlight |
| Immune response | Use cautiously in immune disorders |
Usage
Dosage & Application
Because Imiquad is a potent immune modulator, frequency depends entirely on the condition being treated.
| Indication | Typical Frequency |
| Actinic Keratosis | Usually 2 times per week (e.g., Mon/Thu) for 16 weeks |
| Superficial Basal Cell Carcinoma | Usually 5 times per week (e.g., Mon-Fri) for 6 weeks |
| External Genital Warts | Usually 3 times per week (e.g., Mon/Wed/Fri) |
Administration
Application: Apply a thin layer of the cream to the affected area and rub it in until it disappears.
Hygiene: Wash your hands thoroughly before and after applying the cream.
Duration: Leave the cream on the skin for the time specified by your doctor (usually 6–10 hours), then wash the area with mild soap and water.
Sachet Use: Each sachet is for single use. Discard any remaining cream in the sachet after the dose is applied; do not save it for later.
Consistency: Adhere strictly to the schedule prescribed, even if the area looks like it is healing or becoming irritated.
Uses
Actinic Keratosis: Treats small, rough, scaly patches on sun-damaged skin that are considered precancerous.
Superficial Basal Cell Carcinoma: Indicated for biopsy-confirmed superficial non-melanoma skin cancer when surgery is not considered appropriate.
External Genital and Perianal Warts: Used to treat external warts in adults.
Immune Modulation: Acts as a topical trigger to enhance the local immune response against pathogens or abnormal cell growth.
Side effects
Common side effects
- Redness at application site
- Itching or burning sensation
- Skin irritation or dryness
- Peeling or flaking of skin
Local skin reactions
- Swelling or tenderness
- Scabbing or crusting
- Small sores or ulceration
- Skin discoloration
General effects
- Fatigue
- Headache
- Mild fever or flu-like symptoms
- Muscle aches
Less common side effects
- Nausea
- Diarrhea
- Swollen lymph nodes
- Back pain
Serious side effects (rare)
- Severe skin reactions with intense inflammation
- Allergic reactions such as rash, swelling, or breathing difficulty
- Persistent ulceration or infection at application site
- Severe flu-like symptoms
Side effects summary table
| System affected | Possible reaction |
|---|---|
| Skin (local) | Redness, irritation, peeling, ulceration |
| General | Fatigue, headache, fever |
| Gastrointestinal | Nausea, diarrhea |
| Immune | Swollen lymph nodes |
| Serious risks | Severe skin reactions, allergic response |
FAQs
Q: What is Imiquad used for?
A: Imiquad Sachet, containing Imiquimod, is a prescription immune response modifier used for the topical treatment of specific skin conditions, including actinic keratosis, superficial basal cell carcinoma, and external genital warts.
Q: How does Imiquad work?
A: Unlike traditional creams, it works by activating your body's own immune system to identify and attack abnormal skin cells or viral lesions. It triggers the release of natural chemicals (like interferon) in the skin to help clear the affected area.
Q: Should I be concerned about the redness and irritation at the application site?
A: It is normal to experience redness, swelling, scaling, or crusting. This is actually a sign that your immune system is responding to the medication and working on the targeted cells. However, if the irritation becomes severe, painful, or you develop signs of infection (pus, fever), contact your doctor immediately.
Q: How long do I keep the cream on my skin?
A: The duration varies depending on the condition being treated and your doctor's specific protocol. Generally, the cream should be left on the skin for a set number of hours (e.g., 6 to 10 hours) before being washed off with mild soap and water. Always follow your doctor's instructions for your specific diagnosis.
Q: Can I use this on healthy skin around the target area?
A: No, you should apply it only to the target lesions or affected area. Avoid getting the cream in your eyes, nose, or mouth, and try to minimize contact with healthy skin to prevent unnecessary irritation.
Q: What if I miss a dose?
A: Apply the missed dose as soon as you remember, then continue with your regular schedule. Do not apply a double dose to make up for a missed one.
Q: Can I go out in the sun while using Imiquad?
A: You should minimize exposure to sunlight, including sunlamps, while using Imiquad, as the treated skin may be more sensitive to light. Wear protective clothing and use sunscreen on non-treated areas if you must be outdoors.
Q: Is it safe for pregnant or breastfeeding individuals?
A: Always inform your doctor if you are pregnant, planning to become pregnant, or breastfeeding before starting this medication. They will weigh the potential benefits against any risks for your specific situation.
Interactions
Drug interactions of Imiquad Sachet (Imiquimod Cream)
Topical skin products
- Other medicated creams or ointments may increase skin irritation
- Avoid using multiple topical treatments on the same area unless advised
- Harsh skincare products (peels, exfoliants) may worsen reactions
- Maintain spacing between different topical applications
Immunosuppressive medicines
- Drugs that suppress the immune system may reduce effectiveness of Imiquimod
- Corticosteroids (topical or systemic) may counteract its immune response
- Use with caution in patients on immunotherapy
Dermatological procedures
- Recent skin treatments (laser, cryotherapy, chemical peels) may increase irritation
- Allow proper healing time before starting Imiquimod
- Inform doctor about ongoing or recent skin procedures
General medication considerations
- Minimal systemic absorption, so major drug interactions are rare
- Herbal or alternative skin products may affect treatment response
- Always inform doctor about all current medications and skincare products
Lifestyle and usage considerations
- Avoid sexual contact on treated areas during use
- Do not cover treated area with occlusive dressings unless advised
- Follow prescribed schedule strictly for best results
Drug interactions table
| Interaction type | Effect |
|---|---|
| Other topical creams | Increased irritation or reduced effectiveness |
| Corticosteroids/immunosuppressants | Reduced immune response and effectiveness |
| Skin procedures | Increased sensitivity and irritation |
| Harsh skincare products | Worsened skin reactions |
| Herbal/topical products | Unpredictable effects on treatment |
| Manufacturer | : | Glenmark Pharma, India |
| Trade Name | : | Aldara Cream |
| Generic Search | : | Imiquimod |
| Strength | : | 0.5% |
Latest Products
